Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Earp

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Methods in Enzymology|November 13, 2003
Receptor-activated binding of viral fusion proteins to target membranesLaurie J Earp, Lorraine D Hernandez, Sue E Delos, et al.
Current Topics in Microbiology and Immunology|December 22, 2004
The many mechanisms of viral membrane fusion proteinsL J Earp, S E Delos, H E Park, et al.
The Biochemical Journal|August 15, 1990
The construction of Bacillus thuringiensis strains expressing novel entomocidal delta-endotoxin combinationsN Crickmore, C Nicholls, D J Earp, et al.
Archives of Internal Medicine|June 1, 1986
Mitral valve prolapse. Disease or illness?S M Retchin, R H Fletcher, J Earp, et al.
Journal of Virology|February 14, 2003
The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pHLaurie J Earp, Sue E Delos, Robert C Netter, et al.
Journal of General Internal Medicine|March 1, 1990
Pap tests of rural black womenJ A Sawyer, J Earp, R H Fletcher, et al.
Forensic Science International. Genetics|July 20, 2020
Determination of human identity from Anopheles stephensi mosquito blood meals using direct amplification and massively parallel sequencingShayna L Gray, Teresa M Tiedge, Joann M Butkus, et al.
Journal of Virology|November 27, 2004
Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediateRobert C Netter, Sean M Amberg, John W Balliet, et al.
Journal of Medicinal Chemistry|October 19, 2017
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 ModulatorsMarkus Boehm, Kevin Beaumont, Rhys Jones, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F ActivityShilpa Singh, Catherine E Gleason, Min Fang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Methods in Enzymology|November 13, 2003
Receptor-activated binding of viral fusion proteins to target membranesLaurie J Earp, Lorraine D Hernandez, Sue E Delos, et al.
Current Topics in Microbiology and Immunology|December 22, 2004
The many mechanisms of viral membrane fusion proteinsL J Earp, S E Delos, H E Park, et al.
The Biochemical Journal|August 15, 1990
The construction of Bacillus thuringiensis strains expressing novel entomocidal delta-endotoxin combinationsN Crickmore, C Nicholls, D J Earp, et al.
Archives of Internal Medicine|June 1, 1986
Mitral valve prolapse. Disease or illness?S M Retchin, R H Fletcher, J Earp, et al.
Journal of Virology|February 14, 2003
The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pHLaurie J Earp, Sue E Delos, Robert C Netter, et al.
Journal of General Internal Medicine|March 1, 1990
Pap tests of rural black womenJ A Sawyer, J Earp, R H Fletcher, et al.
Forensic Science International. Genetics|July 20, 2020
Determination of human identity from Anopheles stephensi mosquito blood meals using direct amplification and massively parallel sequencingShayna L Gray, Teresa M Tiedge, Joann M Butkus, et al.
Journal of Virology|November 27, 2004
Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediateRobert C Netter, Sean M Amberg, John W Balliet, et al.
Journal of Medicinal Chemistry|October 19, 2017
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 ModulatorsMarkus Boehm, Kevin Beaumont, Rhys Jones, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F ActivityShilpa Singh, Catherine E Gleason, Min Fang, et al.
Pageof 3